Do you thrive in developing and implementing initiatives and projects intended to make a positive and real impact on both the community and our environment?
Gubra is experiencing rapid growth these years and we are now looking for a Head of ESG. As our new Head of ESG you will act as the focal point for Gubra's ESG initiatives and projects. You will be reporting to our Chief Business Officer and work closely with the executive management team and all functions across Gubra. As Head of ESG you are expected to develop, implement, and execute projects related to Gubra’s ESG strategy and vision.
Your responsibilities will include:
Key Requirements:
Please apply no later than March 9, 2025 by uploading your motivated cover letter, resume and relevant diplomas on our website. If you have questions about the position, please contact Trine Nygaard Hamann, CBO, tnh@gubra.dk.
Please note that applications will be reviewed on an ongoing basis.
About Gubra
Gubra is an ambitious contract research organisation (CRO) and biotech company striving for excellence at all levels. We insist on doing things efficiently – and often differently - to achieve the results we aim for. Our vision is to become leaders in the fight for a healthier and more sustainable world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.
Gubra’s activities are focused on the early stages of drug development and are organised in two highly synergistic business areas: CRO Services and Discovery & Partnerships (D&P). We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.
Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.
People are our greatest asset, and our team consists of +260 employees all located in Hørsholm, Denmark. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!
Check out www.gubra.dk for more inspiration.